29.2 KB of tabular data from a multi-method analysis of the Global Burden of Disease 2023 estimates. The dataset compares age-standardized prevalence, trends, and shared risk factors for gastroesophageal reflux disease (GERD) and asthma across East Asia, Tropical Latin America, and High-income North America from 1994 to 2023. It was authored by Yinghan Deng and published on figshare in March 2026.
Use Cases
- Modeling regional disease trajectories based on age-standardized prevalence rates for GERD and asthma.
- Analyzing associations between lifestyle/metabolic risk factors (e.g., diet, fasting glucose) and disease burden.
- Forecasting future disease burden (2024-2033) for GERD and asthma using time-series methods.
- Investigating geographic heterogeneity in risk factor effects using region-interaction models.
Strengths
- Data is derived from the Global Burden of Disease 2023 estimates, a standardized global source.
- Analysis covers a 30-year time range (1994-2023) and includes forecasts to 2033.
- Results include specific prevalence figures (e.g., 16,591 per 100,000 in Tropical Latin America) and relative risk estimates with confidence intervals.
Limitations
- Row count and column-level documentation are absent; field semantics must be inferred after download.
- Geographic scope is limited to three specific global regions.
- The dataset is small (29.2 KB), indicating a limited, likely aggregated or summary-level scope.
Provenance
- Source
- Global Burden of Disease (GBD) 2023 estimates.
- Collection Method
- Multi-method analysis including Joinpoint regression, ETS/ARIMA forecasting, Random Forest with SHAP, and negative binomial regression.
- Time Range
- 1994 to 2023, with forecasts to 2033.
- Freshness
- Last updated 2026-03-26 06:23:10.
- Geography
- East Asia, Tropical Latin America, and High-income North America.